NY1 Exclusive: City Schools Missing Critical Health Forms For Majority Of … – NY1


NY1

NY1 Exclusive: City Schools Missing Critical Health Forms For Majority Of
NY1
"Each child should have a plan that can effectively control their asthma, and this should allow them to focus on learning while they're in school," said Dr. Delaney Gracy of the Children's Health Fund. Schools, though, can't help, or even let students

and more »

View full post on asthma – Google News

Nitric oxide and its metabolites in the critical phase of illness: rapid biomarkers in the making.

Related Articles

Nitric oxide and its metabolites in the critical phase of illness: rapid biomarkers in the making.

Open Biochem J. 2013;7:24-32

Authors: Mian AI, Aranke M, Bryan NS

Abstract
The potential of nitric oxide (NO) as a rapid assay biomarker, one that could provide a quantum leap in acute care, remains largely untapped. NO plays a crucial role as bronchodilator, vasodilator and inflammatory mediator. The main objective of this review is to demonstrate how NO is a molecule of heavy interest in various acute disease states along the emergency department and critical care spectrum: respiratory infections, central nervous system infections, asthma, acute kidney injury, sepsis, septic shock, and myocardial ischemia, to name just a few. We discuss how NO and its oxidative metabolites, nitrite and nitrate, are readily detectable in several body compartments and fluids, and as such they are associated with many of the pathophysiological processes mentioned above. With methods such as high performance liquid chromatography and chemiluminescence these entities are relatively easy and inexpensive to analyze. Emphasis is placed on diagnostic rapidity, as this relates directly to quality of care in acute care situations. Further, a rationale is provided for more bench, translational and clinical research in the field of NO biomarkers for such settings. Developing standard protocols for the aforementioned disease states, centered on concentrations of NO and its metabolites, can prove to revolutionize diagnostics and prognostication along a spectrum of clinical care. We present a strong case for developing these biomarkers more as point-of-care assays with potential of color gradient test strips for rapid screening of disease entities in acute care and beyond. This will be relevant to global health.

PMID: 23539501 [PubMed – in process]

View full post on pubmed: asthma

Pycnogenol® (French Maritime Pine Bark Extract) Reduces Critical Asthma … – Sacramento Bee

Pycnogenol® (French Maritime Pine Bark Extract) Reduces Critical Asthma
Sacramento Bee
HOBOKEN, N.J., Nov. 7, 2012 — /PRNewswire/ — A new study gives hope to the almost 25 million Americans suffering from asthma. Those afflicted with asthma know the discomfort of asthma symptoms, particularly dependence on an inhaler and awakening

and more »

View full post on asthma – Google News

Young asthmatics are leaving emergency rooms missing critical documentation – EurekAlert (press release)

Young asthmatics are leaving emergency rooms missing critical documentation
EurekAlert (press release)
It sounds unbelievably simple but it's true – a written action plan for asthma treatment, attached to the drug prescription, improves asthma control in children. "Acute care visits for asthma often signal a management failure," said Dr. Francine

and more »

View full post on asthma – Google News

Critical Therapeutics Inc. Reports Operating Results (10-K) – GuruFocus.com

Critical Therapeutics Inc. Reports Operating Results (10-K)
GuruFocus.com
Asthma is a chronic respiratory disease characterized by the narrowing of the lung airways, making breathing difficult. An asthma attack leaves the victim short of breath as the airways become constricted and inflamed. The National Center for Health
Cornerstone Therapeutics 4Q profit falls on expenses, but results top Wall CanadianBusiness.com

all 4 news articles »

View full post on asthma – Google News